Tweet
Translation Google
First Monkeypox Case in Indonesia Confirmed
Rokom by Rokom August 20, 2022
Jakarta, August 20, 2022
The Ministry of Health confirmed that one Indonesian citizen was confirmed to have monkeypox. The patient was a 27-year-old man, with a history of travel to the Netherlands, Switzerland, Belgium and France before contracting the infection.
Based on the investigation, the patient traveled abroad between July 22 and arrived back in Jakarta on August 8, 2022. The patient began to experience early symptoms of monkeypox on August 11, 2022.
After consulting with several health facilities, the patient was admitted to a hospital belonging to the Ministry of Health. Health on August 18th and the results of the patient's PCR test confirmed positive on the evening of August 19th.
“Currently the patient is in good condition, not seriously ill and has smallpox or rashes on the face, on the palms of the hands and feet. Patients do not need to be hospitalized, but self-isolation is sufficient,” said the Spokesperson for the Indonesian Ministry of Health, dr. Mohammad Syahril, Sp.P, MPH in a press statement (20/8).
dr. Syahril appealed to the public not to panic because the transmission and fatality of monkeypox were very low compared to Covid-19. As an illustration, there are currently 39,718 confirmed cases of monkeypox worldwide but only 12 people died, or less than 0.001% of the total cases.
Transmission of monkeypox is not as easy as COVID-19 through droplets in the air.
"Monkeypox transmission is through close contact," said Dr. Syahril.
The confirmation of the first monkeypox case in Indonesia has been followed up by the DKI Jakarta Health Office together with the Directorate of Disease Prevention and Control of the Ministry of Health to carry out surveillance to the community or close contacts of patients.
As a form of vigilance, added dr. Syahril, the Ministry of Health has carried out intensive monitoring at all entrances to Indonesia, both from the air, sea, and land that are in direct contact with countries that have reported cases of monkeypox. Around 89 countries have reported cases of monkeypox in their country.
The government has also given an alert status to all airlines and ports to jointly provide a vigilance if there are passengers who have symptoms of monkeypox.
The next step, said dr. Syahril, his party has provided socialization and education to the entire community, all health workers, and all health care facilities to be aware of monkeypox.
dr. Syahril reminded the entire community to always practice clean and healthy living behavior (PHBS) and improve health protocols.
"This health protocol is not only for monkeypox but also for all infectious diseases," said dr. Syahril.
The government has provided guidelines to all Health Offices in Indonesia, all hospitals, and all Puskesmas to give more attention to monkeypox. He hopes that there are no health workers in any health facilities who do not understand monkeypox, because this is part of the vigilance.
At present, PCR testing for monkeypox can only be carried out in two places, namely at the BKPK Ministry of Health's national reference laboratory and the Bogor Agricultural Institute laboratory.
Currently in the process of adding 10 improved laboratories to carry out the PCR examination. There are also several hospitals that are already able to perform PCR.
Said dr. Syahril, the Ministry of Health has prepared 1,200 reagents for monkeypox examination. Examination is carried out when there is a suspicion of monkeypox.
“This monkeypox PCR examination is different from the COVID-19 PCR examination. PCR monkeypox is done by swab on the rashes on the patient's body," said dr. Syahril.
Monkeypox patients also don't need isolation rooms like COVID-19 patients. The isolation room for COVID-19 patients requires negative pressure, while for monkeypox patients the isolation room is not required.
Therapy Clinical treatment for monkeypox should be fully optimized to relieve symptoms, manage complications, and prevent long-term sequelae. Patients should be given fluids, drugs and food to maintain adequate nutrition.
Secondary bacterial infections should be treated as indicated. An antiviral known as tecovirimat developed for smallpox was licensed by the European Medicines Agency (EMA) for monkeypox in 2022 based on data on animal and human studies.
Tecovirimat is not yet widely available. If used for patient care, tecovirimate should ideally be monitored in the context of clinical research with prospective data collection.
Regarding vaccination, WHO has not provided recommendations for mass vaccination against monkeypox. There are two or three countries that have already vaccinated and Indonesia is also in the process of procuring it and must go through a recommendation from the POM.
Monkeypox patients will recover on their own if there are no additional infections or there are no severe comorbidities that can worsen the patient's condition.
"If the patient has no comorbidities and no other aggravating disease, God willing, this patient can actually recover on his own," said dr. Syahril.
The symptoms of monkeypox are similar to the symptoms of chickenpox, but milder. Symptoms begin with fever, headache, muscle aches, and fatigue. The main difference between the symptoms of chickenpox and monkeypox is that monkeypox causes swelling of the lymph nodes (lymphadenopathy) whereas chickenpox does not.
Monkeypox is usually a self-limiting disease with symptoms lasting from 2 to 4 weeks.
This news was broadcast by the Bureau of Communications and Public Services, Ministry of Health of the Republic of Indonesia. For further information, please contact the Halo Ministry of Health hotline number via hotline 1500-567, SMS 081281562620, facsimile (021) 5223002, 52921669, and email address contact@kemkes.go.id (D2).
Head of the Bureau of Communication and Public Services,
drg. Widyawati, MKM
First Monkeypox Case in Indonesia Confirmed
Rokom by Rokom August 20, 2022
Jakarta, August 20, 2022
The Ministry of Health confirmed that one Indonesian citizen was confirmed to have monkeypox. The patient was a 27-year-old man, with a history of travel to the Netherlands, Switzerland, Belgium and France before contracting the infection.
Based on the investigation, the patient traveled abroad between July 22 and arrived back in Jakarta on August 8, 2022. The patient began to experience early symptoms of monkeypox on August 11, 2022.
After consulting with several health facilities, the patient was admitted to a hospital belonging to the Ministry of Health. Health on August 18th and the results of the patient's PCR test confirmed positive on the evening of August 19th.
“Currently the patient is in good condition, not seriously ill and has smallpox or rashes on the face, on the palms of the hands and feet. Patients do not need to be hospitalized, but self-isolation is sufficient,” said the Spokesperson for the Indonesian Ministry of Health, dr. Mohammad Syahril, Sp.P, MPH in a press statement (20/8).
dr. Syahril appealed to the public not to panic because the transmission and fatality of monkeypox were very low compared to Covid-19. As an illustration, there are currently 39,718 confirmed cases of monkeypox worldwide but only 12 people died, or less than 0.001% of the total cases.
Transmission of monkeypox is not as easy as COVID-19 through droplets in the air.
"Monkeypox transmission is through close contact," said Dr. Syahril.
The confirmation of the first monkeypox case in Indonesia has been followed up by the DKI Jakarta Health Office together with the Directorate of Disease Prevention and Control of the Ministry of Health to carry out surveillance to the community or close contacts of patients.
As a form of vigilance, added dr. Syahril, the Ministry of Health has carried out intensive monitoring at all entrances to Indonesia, both from the air, sea, and land that are in direct contact with countries that have reported cases of monkeypox. Around 89 countries have reported cases of monkeypox in their country.
The government has also given an alert status to all airlines and ports to jointly provide a vigilance if there are passengers who have symptoms of monkeypox.
The next step, said dr. Syahril, his party has provided socialization and education to the entire community, all health workers, and all health care facilities to be aware of monkeypox.
dr. Syahril reminded the entire community to always practice clean and healthy living behavior (PHBS) and improve health protocols.
"This health protocol is not only for monkeypox but also for all infectious diseases," said dr. Syahril.
The government has provided guidelines to all Health Offices in Indonesia, all hospitals, and all Puskesmas to give more attention to monkeypox. He hopes that there are no health workers in any health facilities who do not understand monkeypox, because this is part of the vigilance.
At present, PCR testing for monkeypox can only be carried out in two places, namely at the BKPK Ministry of Health's national reference laboratory and the Bogor Agricultural Institute laboratory.
Currently in the process of adding 10 improved laboratories to carry out the PCR examination. There are also several hospitals that are already able to perform PCR.
Said dr. Syahril, the Ministry of Health has prepared 1,200 reagents for monkeypox examination. Examination is carried out when there is a suspicion of monkeypox.
“This monkeypox PCR examination is different from the COVID-19 PCR examination. PCR monkeypox is done by swab on the rashes on the patient's body," said dr. Syahril.
Monkeypox patients also don't need isolation rooms like COVID-19 patients. The isolation room for COVID-19 patients requires negative pressure, while for monkeypox patients the isolation room is not required.
Therapy Clinical treatment for monkeypox should be fully optimized to relieve symptoms, manage complications, and prevent long-term sequelae. Patients should be given fluids, drugs and food to maintain adequate nutrition.
Secondary bacterial infections should be treated as indicated. An antiviral known as tecovirimat developed for smallpox was licensed by the European Medicines Agency (EMA) for monkeypox in 2022 based on data on animal and human studies.
Tecovirimat is not yet widely available. If used for patient care, tecovirimate should ideally be monitored in the context of clinical research with prospective data collection.
Regarding vaccination, WHO has not provided recommendations for mass vaccination against monkeypox. There are two or three countries that have already vaccinated and Indonesia is also in the process of procuring it and must go through a recommendation from the POM.
Monkeypox patients will recover on their own if there are no additional infections or there are no severe comorbidities that can worsen the patient's condition.
"If the patient has no comorbidities and no other aggravating disease, God willing, this patient can actually recover on his own," said dr. Syahril.
The symptoms of monkeypox are similar to the symptoms of chickenpox, but milder. Symptoms begin with fever, headache, muscle aches, and fatigue. The main difference between the symptoms of chickenpox and monkeypox is that monkeypox causes swelling of the lymph nodes (lymphadenopathy) whereas chickenpox does not.
Monkeypox is usually a self-limiting disease with symptoms lasting from 2 to 4 weeks.
This news was broadcast by the Bureau of Communications and Public Services, Ministry of Health of the Republic of Indonesia. For further information, please contact the Halo Ministry of Health hotline number via hotline 1500-567, SMS 081281562620, facsimile (021) 5223002, 52921669, and email address contact@kemkes.go.id (D2).
Head of the Bureau of Communication and Public Services,
drg. Widyawati, MKM
